Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.5 - $2.66 $8,601 - $45,757
-17,202 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.87 - $4.77 $7,689 - $19,614
-4,112 Reduced 19.29%
17,202 $40,000
Q4 2021

Feb 15, 2022

SELL
$3.5 - $8.42 $1,344 - $3,233
-384 Reduced 1.77%
21,314 $101,000
Q3 2021

Nov 15, 2021

SELL
$6.03 - $7.95 $206,002 - $271,595
-34,163 Reduced 61.16%
21,698 $172,000
Q2 2021

Aug 16, 2021

SELL
$6.32 - $8.38 $78,456 - $104,029
-12,414 Reduced 18.18%
55,861 $389,000
Q4 2020

Feb 16, 2021

BUY
$7.02 - $9.83 $34,833 - $48,776
4,962 Added 7.84%
68,275 $537,000
Q2 2020

Aug 17, 2020

BUY
$4.01 - $11.04 $90,481 - $249,106
22,564 Added 55.37%
63,313 $586,000
Q1 2020

May 13, 2020

BUY
$3.51 - $8.48 $1,635 - $3,951
466 Added 1.16%
40,749 $190,000
Q2 2019

Aug 14, 2019

BUY
$6.1 - $8.78 $65,312 - $94,007
10,707 Added 36.2%
40,283 $276,000
Q1 2019

May 09, 2019

BUY
$7.6 - $9.4 $28,743 - $35,550
3,782 Added 14.66%
29,576 $238,000
Q4 2018

Feb 13, 2019

BUY
$6.51 - $10.19 $5,500 - $8,610
845 Added 3.39%
25,794 $193,000
Q2 2018

Aug 14, 2018

BUY
$7.87 - $10.89 $196,348 - $271,694
24,949 New
24,949 $264,000

Others Institutions Holding AGLE

# of Institutions
1
Shares Held
241K
Call Options Held
0
Put Options Held
0

About Aeglea BioTherapeutics, Inc.


  • Ticker AGLE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,172,500
  • Market Cap $1.69B
  • Description
  • Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...
More about AGLE
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.